Pfizer and BioNTech’s Covid-19/flu combination vaccine falters in Phase III readout – Pharmaceutical Technology
Pfizer and BioNTech have announced that a Phase III trial studying their investigational combination mRNA vaccine for the treatment of influenza and Covid-19 has failed